Yukihiro Nishio
Overview
Explore the profile of Yukihiro Nishio including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
417
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Egawa-Takata T, Ueda Y, Ito K, Hori K, Tadahiro S, Nagasawa T, et al.
Cancer Sci
. 2022 Feb;
113(5):1693-1701.
PMID: 35218673
This study evaluated the feasibility and efficacy of three postoperative adjuvant chemotherapy regimens for endometrial cancer. Endometrioid cancer patients with intermediate-risk stage I and II or high-risk stage III and...
2.
Komura N, Mabuchi S, Sawada K, Nishio Y, Kimura T, Komura H
Clin Endocrinol (Oxf)
. 2021 Feb;
95(1):163-168.
PMID: 33617655
Objective: Turner syndrome (TS) is a congenital disease characterized by delayed puberty, ovarian dysgenesis and short stature. Although most patients are diagnosed with primary amenorrhea, approximately 15-20% of patients with...
3.
Nakagawa M, Egawa-Takata T, Kamino Y, Otoshi A, Fukuda Y, Tokugawa Y, et al.
Int J Surg Case Rep
. 2020 Jun;
72:156-159.
PMID: 32535532
Introduction: Ventriculoperitoneal (VP shunts) and lumboperitoneal shunts (LP shunts) are used to treat hydrocephalus. The effectiveness of LP shunts has recently been demonstrated. Due to population aging, the number of...
4.
Tanaka Y, Ueda Y, Nakagawa S, Matsuzaki S, Kobayashi E, Shiki Y, et al.
Cancer Chemother Pharmacol
. 2018 Jul;
82(4):585-592.
PMID: 30030584
Purpose: Development of new treatment strategies for endometrial cancer that has become refractory or resistant to taxane/platinum is a critical need. The present study was a phase I/II study of...
5.
Yokosaka S, Izawa A, Sakai C, Sakurada E, Morita Y, Nishio Y
Bioorg Med Chem
. 2018 Feb;
26(8):1643-1652.
PMID: 29454703
Dolastatin 10 (1) is a highly potent cytotoxic microtubule inhibitor (cytotoxicity IC < 5.0 nM) and several of its analogs have recently been used as payloads in antibody drug conjugates....
6.
Nakamura K, Sawada K, Sugiyama M, Mabuchi S, Hisamatsu T, Nishio Y, et al.
Int J Gynecol Cancer
. 2015 Jan;
25(2):288-95.
PMID: 25569817
Objective: Removal of the ovaries is common during surgery for endometrial cancer. However, because loss of the ovaries can cause several health problems in patients, strategies for the prevention of...
7.
Maenaka T, Egawa-Takata T, Hisamoto K, Kunishige I, Nishio Y, Tsujimoto M
J Obstet Gynaecol Res
. 2014 Mar;
40(5):1450-4.
PMID: 24606575
This case involved a 69-year-old woman who had been taking tamoxifen for 5 years after breast cancer surgery. She was referred to our clinic for endometrial cancer screening when tamoxifen...
8.
Maenaka T, Iwata N, Egawa-Takata T, Fukuda Y, Tsukahara C, Kashihara H, et al.
Gan To Kagaku Ryoho
. 2013 Nov;
40(10):1413-7.
PMID: 24196083
PAX 8 is a paired-box gene that plays an important role in the embryogenesis of the thyroid gland, Müllerian ducts, and renal/upper urinary tract. PAX 8 expression is observed in...
9.
Ueda Y, Miyatake T, Nagamatsu M, Yamasaki M, Nishio Y, Yoshino K, et al.
Eur J Obstet Gynecol Reprod Biol
. 2013 Jul;
170(1):259-63.
PMID: 23880598
Objective: To analyze the efficacy and safety of combination chemotherapy of docetaxel and irinotecan for paclitaxel and carboplatin (TC) -refractory or -resistant ovarian carcinomas and for first treatment of primary...
10.
Kodama M, Komura H, Kodama T, Nishio Y, Kimura T
Endocr J
. 2011 Dec;
59(2):153-9.
PMID: 22139404
Patients with Turner syndrome (TS) almost develop osteoporosis, resulting from chromosomal deficiency and estrogen deficiency by gonadal dysgenesis. The aim of this study was to assess bone mineral density (BMD)...